18 Mar 2026
From early‑stage renal biomarker discovery to therapeutic commercialization, Labcorp delivers a comprehensive suite of renal disease biomarkers designed to advance therapy development. Backed by our worldwide clinical trial testing network, deep renal scientific expertise and flexible commercialization solutions, we help accelerate your therapy from breakthrough discovery to the patients who need it most.